Changes of DCE‐MRI Parameters in Patients with Rheumatoid Arthritis before and after Therapy and Their Value for the Efficacy Evaluation of Patients
Open Access
- 18 October 2021
- journal article
- retracted article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-8
- https://doi.org/10.1155/2021/6848359
Abstract
Objective. To explore the changes of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in patients with rheumatoid arthritis (RA) before and after therapy and their value for the efficacy evaluation of patients. Methods. Totally, 90 patients with RA confirmed in our hospital between January 2018 and January 2020 were enrolled. All of them were examined with a Siemens Magnetom Avanto 1.5T imaging system, and data about the rate of enhancement in early stage (REE) and steep slope maximum (SSmax) were obtained. Then, the disease activity score in 28 joints (DAS-28), REE, and SSmax were analyzed, and the associations of SSmax and REE with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and DAS-28 were investigated. Additionally, the patients were assigned to the acute-stage group and the chronic-stage group according to their time-signal intensity curves after therapy, and the two groups were compared in SSmax, REE, ESR, CRP, and DAS-28. Corresponding receiver operating characteristic (ROC) curves were drawn for the analysis of potential markers for efficacy improvement in patients. Results. After therapy, REE, SSmax, ESR, DAS-28, and CRP in the synovium of all patients declined greatly (all ), with higher levels observed in the acute-stage group than those in the chronic-stage group (all ). SSmax and REE of patients were positively bound up with their ESR, CRP, and DAS-28 (all ). Additionally, according to ROC curve-based analysis, both SSmax and REE can be adopted as biological indexes for distinguishing between patients at the acute phase from those at the chronic stage, and joint detection of them can boost the sensitivity of DAS-28. Conclusion. The SSmax and REE levels in RA patients after treatment were significantly decreased, and the levels in patients in the chronic phase were lower than those in patients in the acute phase. SSmax and REE are highly expressed in RA patients, and the combined detection can enhance the value of DAS-28 in the assessment of RA, and it is worthy of clinical promotion.Keywords
This publication has 27 references indexed in Scilit:
- Quality of life and functional capacity in patients with rheumatoid arthritis – Cross-sectional studyReumatología Clínica, 2018
- Early Diagnosis and Treatment of Rheumatoid ArthritisPrimary Care: Clinics in Office Practice, 2018
- Experimental animal models for rheumatoid arthritisImmunopharmacology and Immunotoxicology, 2018
- Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS‐28‐CRP) to assess rheumatoid arthritis patientsInternational Journal of Rheumatic Diseases, 2017
- Novel treatment strategies in rheumatoid arthritisThe Lancet, 2017
- Pathogenetic insights from the treatment of rheumatoid arthritisThe Lancet, 2017
- Perioperative Considerations in Rheumatoid Arthritis PatientsCurrent Rheumatology Reviews, 2016
- Rheumatoid arthritisThe Lancet, 2016
- ACR/EULAR 2010 rheumatoid arthritis classification criteriaRheumatology, 2012
- Assessment of Synovitis in Erosive Osteoarthritis of the Hand using DCE-MRI and Comparison with that in its Major Mimic, the Psoriatic ArthritisAcademic Radiology, 2011